Bristol-Myers Extends Abilify Sales Pact - WSJ.com

Links shared publicly online about this topic.

  • 2,136
    total visits

Bristol-Myers Extends Abilify Sales Pact - WSJ.com

feeds.wsjonline.com —

Bristol-Myers Squibb will sell the psychiatric drug Abilify into 2015 under a deal with Otsuka Pharmaceutical.

View full resource at feeds.wsjonline.com

Tags: Bipolar Disorder Medication, Schizophrenia Medication, Antipsychotic Medication, Drug, Pharma, Abilify, Bristol-Myers Squibb

  • Share

Most Recently Shared on April 6, 2009 at 2:23 pm By:

WSJHealth WSJ Health

Bristol-Meyers, Otsuka Extend Deal http://tinyurl.com/dk2hvu

3 years ago...

Reply

Retweet

Favorite

Advertisement